tiprankstipranks
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
US Market

Organogenesis Holdings (ORGO) Financial Statements

Compare
439 Followers

Organogenesis Holdings Financial Overview

Organogenesis Holdings's market cap is currently $570.73M. The company's EPS TTM is $0.005; its P/E ratio is 803.57; Organogenesis Holdings is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 482.04M$ 433.14M$ 450.89M$ 468.06M$ 338.30M
Gross Profit$ 366.30M$ 326.66M$ 345.87M$ 353.86M$ 250.98M
Operating Income$ -1.28M$ 12.53M$ 22.30M$ 72.92M$ 27.41M
EBITDA$ -1.28M$ 36.03M$ 40.32M$ 87.00M$ 37.23M
Net Income$ 861.00K$ 4.95M$ 15.53M$ 94.20M$ 17.23M
Balance Sheet
Cash & Short-Term Investments$ 135.57M$ 104.34M$ 102.48M$ 113.93M$ 84.39M
Total Assets$ 497.89M$ 460.02M$ 449.36M$ 443.26M$ 294.49M
Total Debt$ 43.31M$ 119.35M$ 123.79M$ 132.30M$ 84.77M
Net Debt$ -92.26M$ 15.51M$ 21.31M$ 18.37M$ 377.00K
Total Liabilities$ 112.57M$ 181.36M$ 183.69M$ 201.22M$ 148.41M
Stockholders' Equity$ 262.90M$ 278.66M$ 265.67M$ 242.03M$ 146.08M
Cash Flow
Free Cash Flow$ 4.18M$ 6.55M$ -9.04M$ 30.76M$ -14.34M
Operating Cash Flow$ 14.21M$ 30.92M$ 24.86M$ 61.98M$ 6.80M
Investing Cash Flow$ -10.03M$ -24.36M$ -33.90M$ -31.22M$ -24.83M
Financing Cash Flow$ 27.64M$ -5.50M$ -2.20M$ -1.04M$ 42.47M
Currency in USD

Organogenesis Holdings Earnings and Revenue History

Organogenesis Holdings Debt to Assets

Organogenesis Holdings Cash Flow

Organogenesis Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis